FilingSEC EDGAR8-K
Enanta Pharmaceuticals Patent Invalidated by UPC, Infringement Action Dismissed
· SEC accepted
StageCourt Ruling
Filing content
The Unified Patent Court (UPC) ruled that Enanta's patent is invalid, resulting in the dismissal of the company's patent infringement action against Pfizer.
AI summary of the filing. Please also check the source.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…